# Medisafe

> Medisafe is a digital health company that turns the everyday struggle of taking pills on time into a behavior-driven engagement platform. Born from a near-fatal insulin overdose in the founders' own family, it began as a free virtual pillbox app and grew into an enterprise platform - anchored by Medisafe Maestro and its Just-in-Time Interventions (JITI) engine - that pharmaceutical companies use to keep patients on therapy. With more than 13 million users worldwide and 4+ billion doses tracked, Medisafe sits at the intersection of consumer mobile health and the multibillion-dollar problem of medication non-adherence.

- **Founded:** 2012
- **Headquarters:** Boston, Massachusetts, United States
- **Founders:** Omri Shor (Co-Founder & CEO), Rotem Shor (Co-Founder & CTO)
- **Team size:** ~83 employees
- **Products:** Medisafe App, Medisafe Maestro, Just-in-Time Interventions (JITI), Patient Support Solutions
- **Notable:** Grew from a free reminder app to an enterprise platform with 13M+ users and 4B+ doses tracked., Raised $50M+ across rounds, including a $30M Series C led by Sanofi Ventures in 2021., Launched Medisafe Maestro (2020), enabling no-code pharma patient journeys.

## Products & services

- **Medisafe App** — A free, direct-to-consumer mobile app that acts as a virtual pillbox: personalized medication reminders, refill alerts, drug-interaction warnings, health measurements, and a 'Medfriend' feature that alerts family or caregivers when a dose is missed.
- **Medisafe Maestro** — An enterprise platform launched in 2020 that lets pharma brand teams design, deploy, and manage personalized patient journeys across brands and markets without engineering resources.
- **Just-in-Time Interventions (JITI)** — A behavioral engine that learns which message timing and content work best for each user and adapts the experience in real time to improve adherence and persistence.
- **Patient Support Solutions** — Adherence, persistence, access and coordination, caregiver support, financial assistance, and clinical-trial support tools delivered to pharmaceutical partners.

## Achievements

- Grew from a free reminder app to an enterprise platform with 13M+ users and 4B+ doses tracked.
- Raised $50M+ across rounds, including a $30M Series C led by Sanofi Ventures in 2021.
- Launched Medisafe Maestro (2020), enabling no-code pharma patient journeys.
- PATHWAYS work with Eisai and Biogen recognized in the 2025 MedTech Breakthrough Awards.
- NIH-published research supporting its adherence approach (2025).

## Latest updates

- **2021-02** — Closed $30M Series C led by Sanofi Ventures and ALIVE Israel HealthTech Fund, pushing total funding past $50M.
- **2021** — Launched and scaled Medisafe Maestro for pharma patient-journey design.
- **2025** — PATHWAYS (with Eisai and Biogen) recognized in the MedTech Breakthrough Awards; NIH-published research.

## Links

- Website: https://medisafe.com
- LinkedIn: https://www.linkedin.com/company/medisafe-project
- Twitter/X: https://x.com/medisafeapp
- YouTube: https://www.youtube.com/@MedisafeTeam
- Facebook: https://www.facebook.com/MedisafeProject

---

Profile page: https://yespress.io/medisafe
Published by YesPress — https://yespress.io
Last updated: 2026-06-07